🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Bullous pemphigoid (BP) is the most common of the autoimmune blistering ski...
Status
Completed
Location
University of Lubeck
Start Date
2018-09-25
Trial ID
NCT04035733
Treatments Being Tested
Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) in patients with res...
Status
Completed
Location
Dr Saskia Langemeijer
Start Date
2016-02
Trial ID
NCT02591862
Treatments Being Tested
Long term management of patients with complement related diseases including...
Status
Terminated
Location
Instytut Hematologii i Transfuzjologii
Start Date
2017-03-13
Trial ID
NCT03829449
Treatments Being Tested
Multicentre Study of nomacopan in Paediatric Haematopoietic Stem-Cell Trans...
Status
Terminated
Location
Children's Hospital Los Angeles
Start Date
2021-02-01
Trial ID
NCT04784455
Treatments Being Tested
rVA576 for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)....
Status
Completed
Location
Almaty City Hospital No.7
Start Date
2018-06-07
Trial ID
NCT03588026
Treatments Being Tested
Topical rVA576 for treatment of atopic keratoconjunctivitis (AKC), vernal k...
Status
Terminated
Location
Hospital Clinic de Barcelona
Start Date
2019-03-04
Trial ID
NCT04037891
A phase III two-part study of nomacopan, a bifunctional inhibitor of comple...
Status
Withdrawn
Location
Tulane University Health Sciences Center
Start Date
2022-05-06
Trial ID
NCT05061771
Treatments Being Tested